MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma

Diseases of the Colon and Rectum

Volumn 41, Issue 10, 1998, Pages 1262-1272

  Aoki, Rie ^a   Tanaka, Shinji ^a   Haruma, Ken ^a   Yoshihara, Masaharu ^a   Sumii, Koji ^a   Kajiyama, Goro ^a   Shimamoto, Fumio ^b   Kohno, Nobuoki ^c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endoscopic treatment; Ki67; Lymph node metastasis; MUC 1; Submucosal colorectal carcinoma

Indexed keywords

KI 67 ANTIGEN; MUCIN;

ARTICLE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; ENDOSCOPIC SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ANTIBODIES, MONOCLONAL; CA-15-3 ANTIGEN; COLORECTAL NEOPLASMS; ENDOSCOPY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS;

EID: 0031722974     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02258227     Document Type: Article

References (62)

1. Haruma K, Sumii K, Inoue K, Teshima H, Kajiyama G. Endoscopic therapy in patients with inoperable early gastric cancer. Am J Gastroenterol 1990;85:522-6.
2. Karita M, Tada M, Okita M, Kodama M. Endoscopic therapy for early colon cancer: the "strip biopsy" resection technique. Gastrointest Endosc 1991;37:128-32.
3. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 1993;25:455-61.
4. Yokota T, Sugihara K, Yoshida S. Endoscopic mucosal resection for colorectal neoplastic lesions. Dis Colon Rectum 1994;37:1108-11.
5. Usui Y, Kudo K, Satou T, Satou M, Hamada S, Kitamura S. A case of type IIc cancer having submucosal venous invasion without direct submucosal invasion. J Jpn Soc Colo-proctol 1991;44:1089-92.
6. Shatney CH, Lober PH, Gilberson VA, Sosion H. The treatment of pedunculated adenomatous colorectal polyps with focal cancer. Surg Gynecol Obstet 1974;39: 845-50.
7. Shinya H, Cooperman A, Wolff WI. A rational for the endoscopic management of colonic polyps. Surg Clin North Am 1982;65:861-7.
8. Christie JP. Polypectomy or colectomy? Management of 106 consecutively encountered colonic polyps. Am Surg 1988;54:93-9.
9. Langer JC, Cohen Z, Taylor BR, Stafford S, Jeejeebhoy KN, Cullen JB. Management of patients with polyps containing malignancy removed by colonoscopic polypectomy. Dis Colon Rectum 1984;27:6-9.
10. Morson BG, Whiteway JE, Jones EA, Macrae FA, Willams CB. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 1984;25:437-44.
11. Bartnik W, Butruk E, Orlowska J. A conservative approach to adenomas containing invasive carcinoma removed colonoscopically. Dis Colon Rectum 1985;28: 673-5.
12. Conte CG, Welch JP, Tennant R, Folouhar F, Lundy J, Bloom GP. Management of endoscopically removed malignant colon polyps. J Surg Oncol 1987;36:116-21.
13. Wolff WI, Shinya H. Definitive treatment of malignant polyps of the colon. Ann Surg 1975;182:516-25.
14. Shlomo K, Louis RB, Philip HG, Benjamin M. The care of patients with colorectal polyps that contain invasive adenocarcinoma. Cancer 1992;70:2044-50.
15. Minamoto T, Mai M, Ogino T, et al. Early invasive colorectal carcinomas metastatic to the lymph node with attention to their non-polypoid development. Am J Gastroenterol 1993;88:1035-9.
16. Tanaka S, Yokota T, Saito D, Okamoto S, Oguro Y, Yoshida S. Clinicopathologic features of early rectal carcinoma and indications for endoscopic treatment. Dis Colon Rectum 1995;38:959-63.
17. Tanaka S, Haruma K, Teixeira CR, et al. Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 1995;30:710-7.
18. Tanaka S, Haruma K, Tatsuta S, et al. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. Oncology 1995;52:134-9.
19. Texeira CR, Tanaka S, Haruma K, et al. The clinical significance of the histologic subclassification of colorectal carcinoma. Oncology 1993;50:495-9.
20. Texeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G. Proliferating cell nuclear antigen (PCNA) expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 1994; 73:575-9.
21. Irimura T, McIsaac AM, Carlson DA, et al. Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells. Cancer Res 1990;50:3331-8.
22. Dahiya R, Kwak K-S, Byrd JC, Ho S, Yoon W-H, Kim YS. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res 1993;53:1437-43.
23. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265:15286-93.
24. Wreschner DH, Hareuveni M, Tsarfaty I, et al. Human epithelial tumor antigen cDNA sequences: differential splicing may generate multiple protein forms. Eur J Biochem 1990;189:463-73.
25. Gendler SJ, Spicer AP, Lalani E-N, et al. Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis 1991;144(Suppl):42-7.
26. Niv Y, Byrd JC, Ho SB, Dahiya R, Kim YS. Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int J Cancer 1992;50:147-52.
27. Ligtenberg MJ, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res 1992;52:2318-24.
28. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994;106:353-61.
29. Hiraga Y, Tanaka S, Haruma K, et al. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology 1998; 55:307-19.
30. Peat N, Gendler SJ, Lalani E-N, Duhing T, Taylor-Papadimitriou J. Tissue-specific expression of a human polymorphic epithelial mucin (MUC-1) in transgenic mice. Cancer Res 1992;52:1954-60.
31. x expression. Cancer Res 1993;53: 4082-8.
32. Irimura T, Carlson DA, Price J, et al. Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues. Cancer Res 1988;48:2353-60.
33. Yuan M. Mucin core peptide expression in malignant and non-malignant colorectal tissues [in Chinese; English abstract]. Chung Hua Chung Liu Tsa Chih 1992;14: 267-9.
34. Kohno N, Awaya Y, Oyama T, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637-42.
35. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-16.
36. Kohno N, Inoue Y, Hamada H, et al. Difference in sero-diagnostic values among KL-6-associated mucins classified as Cluster 9. Int J Cancer 1994;8(Suppl):81-3.
37. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 1992;102:117-22.
38. Stahel RA, Gilks WR, Lehmann HP, Schenker T. Third International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysis. Int J Cancer 1994;8(Suppl):6-26.
39. Key G, Becker MH, Baron B, et al. New Ki67 equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki67 cDNA containing three 62bp repetitive elements encoding for the Ki67 epitope. Lab Invest 1993;68:629-36.
40. Gerdes J, Becker MH, Cattoretti G. Immunohistochemical detection of tumor growth fraction (Ki67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992;168:85-6.
41. Verheijen R, Kuijpers HJ, Schlingermann RO, Boehmer AL, van Driel R, Brakenhoff GJ. Ki67 detects a nuclear matrix-associated proliferation-related antigen. 1. Intracellular localization during interphase. J Cell Sci 1889; 92:123-30, 531-40.
42. Isola J, Helin H, Kallioniemi OP. Immunohistochemical-microscopic localization of a proliferation associated antigen Ki67 in MCF-7 cells. Histochem J 1990;22: 498-506.
43. Youssef EM, Matsuda T, Tanaka N, et al. Prognostic significance of the MIB-1 proliferation index for the patients with squamous cell carcinoma of the esophagus. Cancer 1995;76:358-66.
44. Walker RA, Camplejohn RS. Comparison of monoclonal antibody Ki67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 1988;57:281-3.
45. Forschen R, Lohe B, Hengels KJ, Borchard F. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki67. Cancer 1989;64:2501-5.
46. Yonemura Y, Ooyama S, Sugiyama K, et al. Growth fraction in gastric carcinomas determined with monoclonal antibody Ki67. Cancer 1990;65:1130-4.
47. Porschen R, Kriegel A, Langen C, et al. Assessment of proliferate activity in carcinomas of human alimentary tract by Ki67 immunostaining. Int J Cancer 1991;47: 686-91.
48. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y, Sugimachi K. Predictive value of Ki67 and argyrophilic nuclear organizer region staining for lymph node metastasis in gastric cancer. Cancer Res 1991;51: 3503-6.
49. Suzuki H, Matsumoto K, Terabe M. Ki67 antibody labeling index in colorectal carcinoma. J Clin Gastroenterol 1992;15:317-20.
50. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Ki67 immunoreactivity, ploidy, and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 1996;53:182-91.
51. Kyzer S, Gordon PH. Determination of proliferate activity in colorectal carcinoma using monoclonal antibody Ki67. Dis Colon Rectum 1997;40:322-5.
52. Tatsuta S, Tanaka S, Haruma K, et al. Combined expression of urokinase-type plasminogen activator and proliferating cell nuclear antigen at the deepest invasive portion correlates with colorectal cancer prognosis. Int J Oncol 1997;10:125-9.
53. Hiraga Y, Tanaka S, Haruma K, et al. Single carcinoma cells at the deepest portion correlated with metastatic potential of advanced colorectal carcinoma. Int J Oncol 1997;10:1141-5.
54. Jass JR, Sobin LH. International Histological Classification on Tumours., 2nd ed. Berlin: Springer-Verlag, 1989:29-33.
55. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
56. Ishi H, Tatsuta M, Tsutsui S, et al. Early depressed adenocarcinomas of the large intestine. Cancer 1992;69: 2406-10.
57. Abulkalam MS, Kato Y, Kunishima N, Sugano H, Trump BF. Carcinoma in situ in nonpolypoid mucosa of the large intestine: report of a case with significance in strategies for early detection. Cancer 1985;56:2849-54.
58. Kuramoto S, Oohara T. Flat early cancers of the large intestine. Cancer 1989;64:950-6.
59. Adachi M, Muto T, Morioka Y, Ikenaga T, Hara M. Flat adenoma and flat mucosal carcinoma (IIb type): a new precursor of colorectal carcinoma? Report of two cases. Dis Colon Rectum 1988;31:236-43.
60. Françoise M, François D, Bertrand N, Berger F, Lambert R. Failure of endoscopic detection of a de novo carcinoma of the colon in patient with adenomatous polyps. Gastrointest Endosc 1992;32:703-6.
61. Oseki Y, Saiga T, Matsubara N, Koyama A, Honma M, Koyama M. Depressed type mucosal cancer of large intestine with converging mucosal folds: report of a case. Dig Endosc 1992;4:153-8.
62. Byron EC, Wayne FS. Small nonpolypoid carcinomas of the large intestine. Cancer 1983;51:1760-3.